Akzo Nobel N.V. (0A00)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 58.29 |
|---|---|
| 52-week range | 44.82 – 67.64 |
| Return, 1 month / 3 months | +3.8% / −0.5% |
| Return, 1 year / 3 years | −0.6% / +1.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 50 |
| Volatility (1 year) | 39.0% |
| Worst drawdown (1 year) | -24.7% |
| Average daily value traded | 9.56M EUR |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Akzo Nobel is a Dutch company based in Amsterdam that makes paints and coatings. It produces decorative paints for households and professional painters, sold under brands including Dulux and Sikkens, and it supplies performance coatings for industry, ships, vehicles and buildings. Its customers range from ordinary homeowners and trade painters to manufacturers and construction firms around the world. The company combines paint manufacturing with chemical coatings technology for a wide variety of surfaces and applications.
The shares are listed on the London Exchange in UK under the code 0A00, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Akzo Nobel N.V. (0A00) trades on the London Exchange in UK. It last closed at EUR 58.29 on 20 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,298 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.6% and over the last three months it fell 0.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.4% | ||
| From 52-week high | -13.1% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.5% | ||
| 6-month return | 12.2% | ||
| 12-month return, skipping the last month | -4.2% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.7% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 9.56M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 80 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | +3.8% |
| 3 months | −0.5% |
| 6 months | +12.2% |
| 1 year | −0.6% |
| 3 years | +1.7% |
| 5 years | −28.5% |
Signals
| 50-day / 200-day average | 58.99 / 56.37 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.18 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Apr 2026 | EUR 1.5400 |
| 27 Oct 2025 | EUR 0.4400 |
| 29 Apr 2025 | EUR 1.5400 |
| 28 Oct 2024 | EUR 0.4400 |
| 29 Apr 2024 | EUR 1.5400 |
| 30 Oct 2023 | EUR 0.4400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.